You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 2, February 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cisplatin Potentiation of Radiotherapy

Long-term Follow-up

Bruce Leipzig, MD; Stephen J. Wetmore, MD; Roberto Putzeys, MD; James Y. Suen, MD; Nancy L. Snyderman, MD

Arch Otolaryngol. 1985;111(2):114-118.


Abstract

• Thirty-three patients with inoperable squamous cell carcinoma of the head and neck were treated with cisplatin, 15 mg/sq m, administered synchronously with high-dose radiation therapy. Twenty-nine patients (88%) responded to the regimen; of these, 20 had complete regression of all disease. Eight of the 20 had a relapse in less than one year of their treatment. Among those patients who did not have a relapse, the follow-up period was short. It is concluded that a clinical regression response is more likely with this treatment regimen than with radiation therapy alone, and that that response may be a better palliation. Further study of this combination of treatment modalities is warranted.

(Arch Otolaryngol 1985;111:114-118)



Author Affiliations

From the Department of Otolaryngology and Maxillofacial Surgery (Drs Leipzig, Wetmore, Suen, and Snyderman), and the Department of Radiology (Dr Putzeys), Division of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock.


Footnotes

Accepted for publication Oct 5, 1984.

Read before the International Conference on Head and Neck Cancer, Baltimore, July 23, 1984.

Reprint requests to Division of Head and Neck Oncology, Department of Otolaryngology, University of Arkansas for Medical Sciences, Slot 538, 4301 W Markham, Little Rock, AR 72205 (Dr Leipzig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preoperative Chemotherapy-Sensitized Radiation Therapy for Cervical Metastases in Head and Neck Cancer
Puc et al.
Arch Otolaryngol Head Neck Surg 2000;126:337-342.
ABSTRACT | FULL TEXT  

Carboplatin-Radiation Interaction in Squamous Cell Carcinoma Cell Lines
Pekkola-Heino et al.
Arch Otolaryngol Head Neck Surg 1992;118:1312-1315.
ABSTRACT  

Cisplatin Sensitization to Radiotherapy in Stage IV Squamous Cell Carcinoma of the Head and Neck: A Follow-up Report
Snyderman et al.
Arch Otolaryngol Head Neck Surg 1986;112:1147-1150.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.